<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="correction" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Endocrinol.</journal-id>
<journal-title>Frontiers in Endocrinology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Endocrinol.</abbrev-journal-title>
<issn pub-type="epub">1664-2392</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fendo.2024.1491855</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Endocrinology</subject>
<subj-group>
<subject>Erratum</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Erratum: Addressing chemically-induced obesogenic metabolic disruption: selection of chemicals for <italic>in vitro</italic> human PPAR&#x3b1;, PPAR&#x3b3; transactivation, and adipogenesis test methods</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<collab>Frontiers Production Office</collab>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/20170"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<institution>Frontiers Media SA</institution>, <addr-line>Lausanne</addr-line>, <country>Switzerland</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Approved by: Frontiers Editorial Office, Frontiers Media SA, Lausanne, Switzerland</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Frontiers Production Office, <email xlink:href="mailto:production.office@frontiersin.org">production.office@frontiersin.org</email>
</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>25</day>
<month>10</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>15</volume>
<elocation-id>1491855</elocation-id>
<history>
<date date-type="received">
<day>05</day>
<month>09</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>05</day>
<month>09</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2024 Frontiers Production Office</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Frontiers Production Office</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<related-article id="RA1" related-article-type="corrected-article" xlink:href="10.3389/fendo.2024.1401120" ext-link-type="doi">An Erratum on <article-title>Addressing chemically-induced obesogenic metabolic disruption: selection of chemicals for <italic>in vitro</italic> human PPAR&#x3b1;, PPAR&#x3b3; transactivation, and adipogenesis test methods</article-title> By Ozcagli E, Kubickova B and Jacobs MN (2024). <italic>Front. Endocrinol.</italic> 15:1401120. doi:&#xa0;<object-id>10.3389/fendo.2024.1401120</object-id>
</related-article>
<kwd-group>
<kwd>adipogenesis</kwd>
<kwd>obesogen</kwd>
<kwd>peroxisome proliferator-activated receptor</kwd>
<kwd>metabolic disruption</kwd>
<kwd>integrated testing strategy</kwd>
<kwd>test guideline</kwd>
<kwd>validation</kwd>
</kwd-group>
<counts>
<fig-count count="0"/>
<table-count count="1"/>
<equation-count count="0"/>
<ref-count count="0"/>
<page-count count="6"/>
<word-count count="850"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>Molecular and Structural Endocrinology</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<p>Due to a production error, there was a mistake in <xref ref-type="table" rid="T2">
<bold>Tables&#xa0;2A&#x2013;C</bold>
</xref> as published. The molecular structures were incorrectly placed in these tables. The corrected <xref ref-type="table" rid="T2">
<bold>Tables&#xa0;2A&#x2013;C</bold>
</xref> appear below.</p>
<table-wrap-group id="T2" position="float">
<label>Table&#xa0;2A</label>
<caption>
<p>Selected chemicals and activity bands for the PPAR&#x3b1; assay.</p>
</caption>
<table-wrap>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="left">Chemical</th>
<th valign="top" align="left">Cas No.</th>
<th valign="top" align="left">Structure</th>
<th valign="top" align="left">Use</th>
<th valign="top" align="left">hPPAR&#x3b1;<break/>ag/antag &#x25cf; <break/>inactive &#x25cb;</th>
</tr>
</thead>
<tbody>
<tr>
<th valign="top" colspan="5" align="left">Negative</th>
</tr>
<tr>
<td valign="top" align="left">
<bold>Bisphenol A (BPA)</bold>
</td>
<td valign="top" align="left">80-05-7</td>
<td valign="top" align="left">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i003.tif"/>
</td>
<td valign="top" align="left">Plasticiser, industrial chemical</td>
<td valign="top" align="left">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i002.tif"/>
<break/>-</td>
</tr>
<tr>
<td valign="top" align="left">
<bold>Triphenylphosphate (TPP)</bold>
</td>
<td valign="top" align="left">115-86-6</td>
<td valign="top" align="left">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i004.tif"/>
</td>
<td valign="top" align="left">Industrial chemical</td>
<td valign="top" align="left">
<bold>
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i002.tif"/>
</bold>
<break/>-</td>
</tr>
<tr>
<td valign="top" align="left">
<bold>Dichlorodiphenyldichloroethylene</bold>
<break/>
<bold>(pp&#x2019;-DDE)</bold>
</td>
<td valign="top" align="left">72-55-9</td>
<td valign="top" align="left">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i005.tif"/>
</td>
<td valign="top" align="left">Pesticide metabolite (Stockholm POPs list)</td>
<td valign="top" align="left">
<bold>
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i002.tif"/>
</bold>
<break/>-</td>
</tr>
<tr>
<td valign="top" align="left">
<bold>Triclosan (TCS)</bold>
</td>
<td valign="top" align="left">3380-34-5</td>
<td valign="top" align="left">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i006.tif"/>
</td>
<td valign="top" align="left">Bacteriocide</td>
<td valign="top" align="left">
<bold>
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i002.tif"/>
</bold>
<break/>-</td>
</tr>
<tr>
<td valign="top" align="left">
<bold>Rosiglitazone (ROSI)</bold>
</td>
<td valign="top" align="left">122320-73-4</td>
<td valign="top" align="left">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i007.tif"/>
</td>
<td valign="top" align="left">Pharmaceutical</td>
<td valign="top" align="left">
<bold>
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i002.tif"/>
</bold>
<break/>
<bold>-</bold>
<break/>
</td>
</tr>
<tr>
<td valign="top" align="left">
<bold>Chlorpyrifos (CPF)</bold>
</td>
<td valign="top" align="left">2921-88-2</td>
<td valign="top" align="left">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i008.tif"/>
</td>
<td valign="top" align="left">Organophosphate pesticide</td>
<td valign="top" align="left">
<bold>
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i002.tif"/>
</bold>
<break/>-</td>
</tr>
<tr>
<td valign="top" align="left">
<bold>Perfluorohexanoic acid (PFHXA)</bold>
</td>
<td valign="top" align="left">307-24-4</td>
<td valign="top" align="left">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i009.tif"/>
</td>
<td valign="top" align="left">Breakdown product of PFAS</td>
<td valign="top" align="left">
<bold>
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i002.tif"/>
</bold>
<break/>
<bold>-</bold>
</td>
</tr>
<tr>
<td valign="top" align="left">
<bold>(aR)-4-chloro-a-[3-(trifluoromethyl)phenoxy]benzeneacetic acid, (MBX-102/JNJ39659100)</bold>
<break/>
<bold>Arhalofenate</bold>
<break/>
<bold>MBX-102</bold>
</td>
<td valign="top" align="left">24136-23-0</td>
<td valign="top" align="left">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i010.tif"/>
</td>
<td valign="top" align="left">Experimental pharmaceutical</td>
<td valign="top" align="left">
<bold>
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i002.tif"/>
</bold>
<break/>
<bold>-</bold>
</td>
</tr>
<tr>
<td valign="top" align="left">
<bold>Tetrabrominated BPA (TBBPA)</bold>
</td>
<td valign="top" align="left">79-94-7</td>
<td valign="top" align="left">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i011.tif"/>
</td>
<td valign="top" align="left">Flame retardant</td>
<td valign="top" align="left">
<bold>
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i002.tif"/>
</bold>
<break/>-/?<break/>
</td>
</tr>
<tr>
<td valign="top" align="left">
<bold>LGD1069 (Targretin) Bexarotene</bold>
</td>
<td valign="top" align="left">153559-49-0</td>
<td valign="top" align="left">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i012.tif"/>
</td>
<td valign="top" align="left">Pharmaceutical</td>
<td valign="top" align="left">
<bold>
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i002.tif"/>
</bold>
<break/>
<bold>-</bold>
</td>
</tr>
<tr>
<th valign="top" colspan="5" align="left">Weak activity</th>
</tr>
<tr>
<td valign="top" align="left">
<bold>Phytanic acid</bold>
</td>
<td valign="top" align="left">14721-66-5</td>
<td valign="top" align="left">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i013.tif"/>
</td>
<td valign="top" align="left">Dietary lipid</td>
<td valign="top" align="left">
<bold>
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i001.tif"/>
</bold>
<break/>+ Very weak agonist 10<sup>-4</sup> &#xb5;M</td>
</tr>
<tr>
<td valign="top" align="left">
<bold>Clofibrate</bold>
</td>
<td valign="top" align="left">637-07-0</td>
<td valign="top" align="left">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i014.tif"/>
</td>
<td valign="top" align="left">Pharmaceutical, fibrate</td>
<td valign="top" align="left">
<bold>
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i001.tif"/>
</bold>
<break/>+ Weak-moderate agonist up to 10<sup>-4</sup> &#xb5;M</td>
</tr>
<tr>
<td valign="top" align="left">
<bold>AGN194204 (IRX4204)</bold>
</td>
<td valign="top" align="left">220619-73-8</td>
<td valign="top" align="left">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i015.tif"/>
</td>
<td valign="top" align="left">Pharmaceutical</td>
<td valign="top" align="left">
<bold>
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i001.tif"/>
</bold>
<break/>Weak antagonist</td>
</tr>
<tr>
<th valign="top" colspan="5" align="left">Weak to moderate activity</th>
</tr>
<tr>
<td valign="top" align="left">
<bold>Mono-(2-Ethylhexyl) Phthalate (MEHP)</bold>
</td>
<td valign="top" align="left">4376-20-9</td>
<td valign="top" align="left">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i016.tif"/>
</td>
<td valign="top" align="left">Phthalate, plasticiser</td>
<td valign="top" align="left">
<bold>
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i001.tif"/>
</bold>
<break/>+ Moderate agonist</td>
</tr>
<tr>
<td valign="top" align="left">
<bold>Eicosapentaenoic acid (EPA)</bold>
</td>
<td valign="top" align="left">10417-94-4</td>
<td valign="top" align="left">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i017.tif"/>
</td>
<td valign="top" align="left">Nutrient, long chain PUFA essential fatty acid</td>
<td valign="top" align="left">
<bold>
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i001.tif"/>
</bold>
<break/>+ Moderate agonist</td>
</tr>
<tr>
<td valign="top" align="left">
<bold>Tesaglitazar/AZ242</bold>
</td>
<td valign="top" align="left">251565-85-2</td>
<td valign="top" align="left">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i018.tif"/>
</td>
<td valign="top" align="left">Pharmaceutical</td>
<td valign="top" align="left">
<bold>
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i001.tif"/>
</bold>
<break/>+ Selective moderate agonist<break/>3 &#xb5;M</td>
</tr>
<tr>
<td valign="top" align="left">
<bold>Clofibric acid</bold>
</td>
<td valign="top" align="left">882-09-7</td>
<td valign="top" align="left">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i019.tif"/>
</td>
<td valign="top" align="left">Herbicide and pharmaceutical; active metabolite of clofibrate</td>
<td valign="top" align="left">
<bold>
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i001.tif"/>
</bold>
<break/>+ Moderate agonist (EC<sub>50</sub> = 50.0 &#xb5;M)</td>
</tr>
<tr>
<th valign="top" colspan="5" align="left">Strong activity</th>
</tr>
<tr>
<td valign="top" align="left">
<bold>Perfluorooctanoic acid (PFOA)</bold>
</td>
<td valign="top" align="left">335-67-1</td>
<td valign="top" align="left">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i020.tif"/>
</td>
<td valign="top" align="left">Industrial chemical, non-stick coating</td>
<td valign="top" align="left">
<bold>
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i001.tif"/>
</bold>
<break/>+ Strong agonist</td>
</tr>
<tr>
<td valign="top" align="left">
<bold>Pristanic acid</bold>
</td>
<td valign="top" align="left">1189-37-3</td>
<td valign="top" align="left">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i021.tif"/>
</td>
<td valign="top" align="left">Dietary lipid</td>
<td valign="top" align="left">
<bold>
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i001.tif"/>
</bold>
<break/>+ Strong agonist<break/>1 &#xb5;M</td>
</tr>
<tr>
<td valign="top" align="left">
<bold>Docosahexaenoic acid (DHA)</bold>
</td>
<td valign="top" align="left">6217-54-5</td>
<td valign="top" align="left">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i022.tif"/>
</td>
<td valign="top" align="left">Nutrient, long chain PUFA essential fatty acid</td>
<td valign="top" align="left">
<bold>
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i001.tif"/>
</bold>
<break/>+ Strong agonist</td>
</tr>
<tr>
<th valign="top" colspan="5" align="left">Positive control</th>
</tr>
<tr>
<td valign="top" align="left">
<bold>GW7647</bold>
</td>
<td valign="top" align="left">265129-71-3</td>
<td valign="top" align="left">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i023.tif"/>
</td>
<td valign="top" align="left">Pharmaceutical candidate</td>
<td valign="top" align="left">
<bold>
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i001.tif"/>
</bold>
<break/>+ Selective agonist, positive control10 nM</td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap>
<label>Table&#xa0;2B</label>
<caption>
<p>Selected chemicals and activity bands for the PPAR&#x3b3; assay.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="left">Chemical</th>
<th valign="top" align="left">Cas No.</th>
<th valign="top" align="left">Structure</th>
<th valign="top" align="left">Use</th>
<th valign="top" align="left">hPPAR&#x3b3; ag/antag &#x25cf; <break/>inactive &#x25cb;</th>
</tr>
</thead>
<tbody>
<tr>
<th valign="top" colspan="5" align="left">Negative</th>
</tr>
<tr>
<td valign="top" align="left">
<bold>Bisphenol A (BPA)</bold>
</td>
<td valign="top" align="left">80-05-7</td>
<td valign="top" align="left">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i024.tif"/>
</td>
<td valign="top" align="left">Plasticiser, industrial chemical</td>
<td valign="top" align="left">
<bold>
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i002.tif"/>
</bold>
<break/>-</td>
</tr>
<tr>
<td valign="top" align="left">
<bold>Dichlorodiphenyldichloroethylene</bold>
<break/>
<bold>(pp&#x2019;-DDE)</bold>
</td>
<td valign="top" align="left">72-55-9</td>
<td valign="top" align="left">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i025.tif"/>
</td>
<td valign="top" align="left">Pesticide metabolite (Stockholm POPs list)</td>
<td valign="top" align="left">
<bold>
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i002.tif"/>
</bold>
<break/>-</td>
</tr>
<tr>
<td valign="top" align="left">
<bold>Triclosan (TCS)</bold>
</td>
<td valign="top" align="left">3380-34-5</td>
<td valign="top" align="left">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i026.tif"/>
</td>
<td valign="top" align="left">Bacteriocide</td>
<td valign="top" align="left">
<bold>
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i002.tif"/>
</bold>
<break/>-</td>
</tr>
<tr>
<td valign="top" align="left">
<bold>Perfluorohexanoic acid (PFHXA)</bold>
</td>
<td valign="top" align="left">307-24-4</td>
<td valign="top" align="left">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i027.tif"/>
</td>
<td valign="top" align="left">Breakdown product of PFAS</td>
<td valign="top" align="left">
<bold>
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i002.tif"/>
</bold>
<break/>
<bold>-</bold>
</td>
</tr>
<tr>
<td valign="top" align="left">
<bold>LGD1069 (Targretin) Bexarotene</bold>
</td>
<td valign="top" align="left">153559-49-0</td>
<td valign="top" align="left">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i028.tif"/>
</td>
<td valign="top" align="left">Pharmaceutical</td>
<td valign="top" align="left">
<bold>
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i002.tif"/>
</bold>
<break/>-</td>
</tr>
<tr>
<th valign="top" colspan="5" align="left">Weak activity</th>
</tr>
<tr>
<td valign="top" align="left">
<bold>Chlorpyrifos (CPF)</bold>
</td>
<td valign="top" align="left">2921-88-2</td>
<td valign="top" align="left">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i029.tif"/>
</td>
<td valign="top" align="left">Organophosphate pesticide</td>
<td valign="top" align="left">
<bold>
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i001.tif"/>
</bold>
<break/>+ Weak agonist</td>
</tr>
<tr>
<td valign="top" align="left">
<bold>Clofibrate</bold>
</td>
<td valign="top" align="left">637-07-0</td>
<td valign="top" align="left">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i030.tif"/>
</td>
<td valign="top" align="left">Pharmaceutical, fibrate</td>
<td valign="top" align="left">
<bold>
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i001.tif"/>
</bold>
<break/>+ Weak-moderate agonist</td>
</tr>
<tr>
<td valign="top" align="left">
<bold>Phytanic acid</bold>
</td>
<td valign="top" align="left">14721-66-5</td>
<td valign="top" align="left">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i031.tif"/>
</td>
<td valign="top" align="left">Dietary lipid</td>
<td valign="top" align="left">
<bold>
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i001.tif"/>
</bold>
<break/>+ Weak-moderate agonist</td>
</tr>
<tr>
<td valign="top" align="left">
<bold>(aR)-4-chloro-a-[3-(trifluoromethyl)phenoxy]benzeneacetic acid, (MBX-102/JNJ39659100)</bold>
<break/>
<bold>Arhalofenate</bold>
<break/>
<bold>MBX-102</bold>
</td>
<td valign="top" align="left">24136-23-0</td>
<td valign="top" align="left">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i032.tif"/>
</td>
<td valign="top" align="left">Experimental pharmaceutical</td>
<td valign="top" align="left">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i001.tif"/>
<break/>+ Weak agonist</td>
</tr>
<tr>
<td valign="top" align="left">
<bold>GW3965 hydrochloride</bold>
</td>
<td valign="top" align="left">405911-17-3</td>
<td valign="top" align="left">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i033.tif"/>
</td>
<td valign="top" align="left">Pharmaceutical candidate</td>
<td valign="top" align="left">
<bold>
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i001.tif"/>
</bold>
<break/>+ Weak agonist</td>
</tr>
<tr>
<th valign="top" colspan="5" align="left">Weak to moderate activity</th>
</tr>
<tr>
<td valign="top" align="left">
<bold>Mono-(2-Ethylhexyl) Phthalate (MEHP)</bold>
</td>
<td valign="top" align="left">4376-20-9</td>
<td valign="top" align="left">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i034.tif"/>
</td>
<td valign="top" align="left">Phthalate, plasticiser</td>
<td valign="top" align="left">
<bold>
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i001.tif"/>
</bold>
<break/>+ Moderate agonist</td>
</tr>
<tr>
<td valign="top" align="left">
<bold>GW7647</bold>
</td>
<td valign="top" align="left">265129-71-3</td>
<td valign="top" align="left">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i035.tif"/>
</td>
<td valign="top" align="left">Pharmaceutical candidate</td>
<td valign="top" align="left">
<bold>
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i001.tif"/>
</bold>
<break/>+ Moderate agonist</td>
</tr>
<tr>
<td valign="top" align="left">
<bold>Eicosapentaenoic acid (EPA)</bold>
</td>
<td valign="top" align="left">10417-94-4</td>
<td valign="top" align="left">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i036.tif"/>
</td>
<td valign="top" align="left">Nutrient, long chain PUFA essential fatty acid</td>
<td valign="top" align="left">
<bold>
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i001.tif"/>
</bold>
<break/>+ Moderate agonist</td>
</tr>
<tr>
<td valign="top" align="left">
<bold>Clofibric acid</bold>
</td>
<td valign="top" align="left">882-09-7</td>
<td valign="top" align="left">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i037.tif"/>
</td>
<td valign="top" align="left">Herbicide and pharmaceutical; active metabolite of clofibrate</td>
<td valign="top" align="left">
<bold>
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i001.tif"/>
</bold>
<break/>+ Weak-Moderate agonist (but weaker than PPAR&#x3b1;)</td>
</tr>
<tr>
<td valign="top" align="left">
<bold>Pristanic acid</bold>
</td>
<td valign="top" align="left">1189-37-3</td>
<td valign="top" align="left">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i038.tif"/>
</td>
<td valign="top" align="left">Dietary lipid</td>
<td valign="top" align="left">
<bold>
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i001.tif"/>
</bold>
<break/>+ Weak-moderate agonist<break/>10 &#xb5;M</td>
</tr>
<tr>
<th valign="top" colspan="5" align="left">Strong activity</th>
</tr>
<tr>
<td valign="top" align="left">
<bold>Triphenyl phosphate (TPP)</bold>
</td>
<td valign="top" align="left">115-86-6</td>
<td valign="top" align="left">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i039.tif"/>
</td>
<td valign="top" align="left">Industrial chemical: Adhesives and sealants, coating products, cosmetics and personal care products</td>
<td valign="top" align="left">
<bold>
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i001.tif"/>
</bold>
<break/>+ Strong agonist</td>
</tr>
<tr>
<td valign="top" align="left">
<bold>Docosahexaenoic acid (DHA)</bold>
</td>
<td valign="top" align="left">6217-54-5</td>
<td valign="top" align="left">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i040.tif"/>
</td>
<td valign="top" align="left">Nutrient, long chain PUFA essential fatty acid</td>
<td valign="top" align="left">
<bold>
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i001.tif"/>
</bold>
<break/>+ Strong agonist</td>
</tr>
<tr>
<td valign="top" align="left">
<bold>Tetrabrominated BPA (TBBPA)</bold>
</td>
<td valign="top" align="left">79-94-7</td>
<td valign="top" align="left">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i041.tif"/>
</td>
<td valign="top" align="left">Flame retardant</td>
<td valign="top" align="left">
<bold>
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i001.tif"/>
</bold>
<break/>+ Strong agonist</td>
</tr>
<tr>
<td valign="top" align="left">
<bold>Perfluorooctanoic acid (PFOA)</bold>
</td>
<td valign="top" align="left">335-67-1</td>
<td valign="top" align="left">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i042.tif"/>
</td>
<td valign="top" align="left">Industrial chemical, non-stick coating</td>
<td valign="top" align="left">
<bold>
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i001.tif"/>
</bold>
<break/>+ Strong agonist</td>
</tr>
<tr>
<td valign="top" align="left">
<bold>15-Deoxy-&#x394;12,14-prostaglandin J2 (15d-PGJ2)</bold>
</td>
<td valign="top" align="left">87893-55-8</td>
<td valign="top" align="left">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i043.tif"/>
</td>
<td valign="top" align="left">Metabolite of endogenous prostaglandin (PGJ2)</td>
<td valign="top" align="left">
<bold>
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i001.tif"/>
</bold>
<break/>+ Strong agonist</td>
</tr>
<tr>
<td valign="top" align="left">
<bold>Tesaglitazar/</bold>
<break/>
<bold>AZ 242</bold>
</td>
<td valign="top" align="left">251565-85-2</td>
<td valign="top" align="left">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i044.tif"/>
</td>
<td valign="top" align="left">Pharmaceutical</td>
<td valign="top" align="left">
<bold>
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i001.tif"/>
</bold>
<break/>+ Strong agonist<break/>40 nM</td>
</tr>
<tr>
<th valign="top" colspan="5" align="left">Positive control</th>
</tr>
<tr>
<td valign="top" align="left">
<bold>Rosiglitazone (ROSI)</bold>
</td>
<td valign="top" align="left">122320-73-4</td>
<td valign="top" align="left">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i045.tif"/>
</td>
<td valign="top" align="left">Pharmaceutical</td>
<td valign="top" align="left">
<bold>
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i001.tif"/>
</bold>
<break/>
<bold>+ Positive control</bold>
</td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap>
<label>Table&#xa0;2C</label>
<caption>
<p>Selected chemicals and activity bands for the hMSC adipogenesis assay.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="left">Chemical</th>
<th valign="top" align="left">Cas No.</th>
<th valign="top" align="left">Structure</th>
<th valign="top" align="left">Use</th>
<th valign="top" align="left">hMSC adipogenesis (lipid <break/>accumulation)<break/>ag/antag &#x25cf; <break/>inactive &#x25cb;</th>
</tr>
</thead>
<tbody>
<tr>
<th valign="top" colspan="5" align="left">Negative</th>
</tr>
<tr>
<td valign="top" align="left">
<bold>Triclosan (TCS)</bold>
</td>
<td valign="top" align="left">3380-34-5</td>
<td valign="top" align="left">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i046.tif"/>
</td>
<td valign="top" align="left">Bacteriocide</td>
<td valign="top" align="left">
<bold>
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i002.tif"/>
</bold>
<break/>-</td>
</tr>
<tr>
<td valign="top" align="left">
<bold>TTNPB, 4-[(E)-2-(5,6,7,8-Tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl] benzoic acid, Arotinoid acid</bold>
</td>
<td valign="top" align="left">71441-28-6</td>
<td valign="top" align="left">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i047.tif"/>
</td>
<td valign="top" align="left">Pharmaceutical</td>
<td valign="top" align="left">
<bold>
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i002.tif"/>
</bold>
<break/>-<break/>Strong inhibitor of adipogenesis; unlike retinoic acids (9cRA) that promotes adipogenesis</td>
</tr>
<tr>
<td valign="top" align="left">
<bold>Dichlorodiphenyldichloroethylene</bold>
<break/>
<bold>(pp&#x2019;-DDE)</bold>
</td>
<td valign="top" align="left">72-55-9</td>
<td valign="top" align="left">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i048.tif"/>
</td>
<td valign="top" align="left">Pesticide metabolite (Stockholm POPs list)</td>
<td valign="top" align="left">
<bold>
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i002.tif"/>
</bold>
<break/>?-</td>
</tr>
<tr>
<td valign="top" align="left">
<bold>Chlorpyrifos (CPF)</bold>
</td>
<td valign="top" align="left">2921-88-2</td>
<td valign="top" align="left">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i049.tif"/>
</td>
<td valign="top" align="left">Organophosphate pesticide</td>
<td valign="top" align="left">
<bold>
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i002.tif"/>
</bold>
<break/>-</td>
</tr>
<tr>
<th valign="top" colspan="5" align="left">Weak activity</th>
</tr>
<tr>
<td valign="top" align="left">
<bold>Perfluorooctanoic acid (PFOA)</bold>
</td>
<td valign="top" align="left">335-67-1</td>
<td valign="top" align="left">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i050.tif"/>
</td>
<td valign="top" align="left">Industrial chemical, non-stick coating</td>
<td valign="top" align="left">
<bold>
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i001.tif"/>
</bold>
<break/>+ Weak inducer</td>
</tr>
<tr>
<th valign="top" colspan="5" align="left">Weak to moderate activity</th>
</tr>
<tr>
<td valign="top" align="left">
<bold>GW3965 hydrochloride</bold>
</td>
<td valign="top" align="left">405911-17-3</td>
<td valign="top" align="left">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i051.tif"/>
</td>
<td valign="top" align="left">Pharmaceutical candidate</td>
<td valign="top" align="left">
<bold>
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i001.tif"/>
</bold>
<break/>+ Weak/moderate inducer</td>
</tr>
<tr>
<td valign="top" align="left">
<bold>Tetrabrominated BPA (TBBPA)</bold>
</td>
<td valign="top" align="left">79-94-7</td>
<td valign="top" align="left">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i052.tif"/>
</td>
<td valign="top" align="left">Flame retardant</td>
<td valign="top" align="left">
<bold>
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i001.tif"/>
</bold>
<break/>+Moderate inducer<break/>10 &#x3bc;M induced adipogenesis in 3T3-L1 cells</td>
</tr>
<tr>
<td valign="top" align="left">
<bold>Mono-(2-Ethylhexyl) Phthalate (MEHP)</bold>
</td>
<td valign="top" align="left">4376-20-9</td>
<td valign="top" align="left">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i053.tif"/>
</td>
<td valign="top" align="left">Phthalate, plasticiser</td>
<td valign="top" align="left">
<bold>
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i001.tif"/>
</bold>
<break/>+ Moderate<break/>10 &#x3bc;M and was maximal at 100 &#x3bc;M</td>
</tr>
<tr>
<td valign="top" align="left">
<bold>Triphenyl phosphate (TPP)</bold>
</td>
<td valign="top" align="left">115-86-6</td>
<td valign="top" align="left">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i054.tif"/>
</td>
<td valign="top" align="left">Industrial chemical: Adhesives and sealants, coating products, cosmetics and personal care products</td>
<td valign="top" align="left">
<bold>
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i001.tif"/>
</bold>
<break/>+ Agonist at high dose (&gt;1&#xb5;M)</td>
</tr>
<tr>
<th valign="top" colspan="5" align="left">Strong activity</th>
</tr>
<tr>
<td valign="top" align="left">
<bold>Fludioxonil</bold>
</td>
<td valign="top" align="left">131341-86-1</td>
<td valign="top" align="left">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i055.tif"/>
</td>
<td valign="top" align="left">Non-systemic fungicide</td>
<td valign="top" align="left">
<bold>
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i001.tif"/>
</bold>
<break/>+ Strong (significant at 0.2 &#xb5;M)</td>
</tr>
<tr>
<td valign="top" align="left">
<bold>Tributyltin (TBT) chloride</bold>
</td>
<td valign="top" align="left">1461-22-9</td>
<td valign="top" align="left">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i056.tif"/>
</td>
<td valign="top" align="left">Fungicide</td>
<td valign="top" align="left">
<bold>
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i001.tif"/>
</bold>
<break/>+ Strong inducer adipogenic differentiation (3T3-L1)</td>
</tr>
<tr>
<th valign="top" colspan="5" align="left">Positive control</th>
</tr>
<tr>
<td valign="top" align="left">
<bold>Rosiglitazone (ROSI)</bold>
</td>
<td valign="top" align="left">122320-73-4</td>
<td valign="top" align="left">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i057.tif"/>
</td>
<td valign="top" align="left">Pharmaceutical</td>
<td valign="top" align="left">
<bold>
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1491855-i001.tif"/>
</bold>
<break/>
<bold>+ Positive control</bold>
</td>
</tr>
</tbody>
</table>
</table-wrap>
</table-wrap-group>
<p>The publisher apologizes for this mistake.</p>
<p>The original version of this article has been updated.</p>
</body>
</article>